Trim 20-25% to lock in rally gains; retain core with $169.54 stop and reload triggers
The asymmetry has narrowed but not flipped — Underweight captures the directional lean without overcommitting. The 8/21 reflection tightened the Underweight sizing cap to 15-20% given noise-level alpha from prior trim-into-strength setups; 20-25% is the calibrated answer that respects the signal without surrendering capital to marginal trim dollars with no payoff asymmetry. Full exit would forfeit asymmetric participation if the Q3 print confirms the $5.64 trailing to $9.78 forward EPS trajectory.
| Position | Action |
|---|---|
| Current position | Trim 20-25% of existing MMM exposure at $178.50 |
| Trimmed residual core | Retain core position sized to ≥75% of prior weight |
| Residual core position | Implement collar: sell $185 call / buy $170 put |
| Confirmed daily close below 50 SMA at $169.54 | Exit residual core position |
| Sustained move above $187 (above entry) | Do not add; stay disciplined to below-entry stop logic |
3M is a repositioned industrial compounder whose worst days are behind it, coiled for the next leg up with depressed TTM EPS masking a 73% earnings recovery, aggressive buybacks reducing share count, and a stable-to-supportive macro backdrop favoring quality compounders.
| Indicator | Value | Signal |
|---|---|---|
| 10 EMA | $179.95 | bearish |
| 50 SMA | $169.54 | bullish |
| 200 SMA | $159.78 | bullish |
| MACD Line | 3.07 | bearish |
| MACD Signal | 4.21 | bearish |
| MACD Histogram | -1.14 | bearish |
| RSI (14) | 56.25 | neutral |
| Bollinger Upper Band | $185.23 | neutral |
| Bollinger Middle Band | $180.46 | neutral |
| Bollinger Lower Band | $175.70 | neutral |
| ATR |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Pullback to $175.70 (lower Bollinger) on declining volume with positive MACD divergence
Then: Re-add to prior weight; structural support retest
· concedes: Consumer segment weakness is real and weighing on the Consumer segment; PFAS litigation tail risk (2023 charges were massive and pre-booked, but framework is working); Strong-dollar FX drag is real (offset by local manufacturing footprint); 8% recession probability exists (soft-landing consensus is firm); 6% odds of CPI >5% (disinflation intact); 87% probability of zero Fed cuts (stable rates, not a re-rate tailwind)
3M is priced for a perfect recovery at the moment momentum has rolled, the Consumer-end market is deteriorating, the macro doesn't ease, and the coiled spring can resolve in either direction — making the risk/reward asymmetrically bearish at $179.
· concedes: Forward P/E of 18.3x is below industrial peer average; Golden cross remains technically intact; Solventum spin-off has removed some litigation complexity; Buybacks do mechanically reduce share count (though at the wrong price); Consumer segment weakness is acknowledged, with Safety & Industrial potentially offsetting
→ vs conservative: Holding at 52-week high with deteriorating momentum (negative MACD histogram, price below 10 EMA and Bollinger middle band) is not conservatism but anchoring bias; the 50 SMA rising before every trend that ever ended
→ vs conservative: Forward P/E of 18.3x with 73% EPS recovery already consensus-priced provides no edge; 'being early' means catching a falling knife if Q3 2026 disappoints
→ vs conservative: Gross margin contraction from 41.2% to 39.9% is not a rounding error but real headwind already showing in numbers
→ vs neutral: Waiting for pullback to $175.70 or $169.54 assumes orderly retracement that Bollinger squeeze (ATR down 26%, bandwidth $15 to $9.50) contradicts; likely outcome is gap through lower band, not orderly entry
→ vs neutral: Technical report explicitly states 'next sustained move out of $175–$185 range is likely the larger directional leg'—being flat during expansion is the most expensive position
→ vs neutral: Time is not free; capital has opportunity cost and every week in MMM at $178 with negative MACD is a week not deployed into cleaner setups
| 3.71 |
| neutral |
| Golden Cross Status | Intact (50 SMA above 200 SMA since spring) | bullish |
Support: 175.7 · 169.54 · 159.78 | Resistance: 180.46 · 184.69 · 184.9 · 185.23
MMM is in a confirmed long-term uptrend with price 5.6% above the 50 SMA ($169.54) and 12.0% above the 200 SMA ($159.78), but near-term momentum has rolled over with MACD crossing below its signal line and histogram at -1.14; the stock is consolidating in the $175–$185 range following a rally from ~$140.47 to an intraday peak of $184.90 on 2026-07-28. Technical indicators suggest a constructive HOLD for existing positions or buying on weakness toward the lower Bollinger Band at $175.70, with a daily close below the 50 SMA ($169.54) needed to shift bias to SELL.
Market Cap
$92.32B
Stock Price
~$178.97
52-Week High
$184.90
52-Week Low
$139.34
50-Day MA
$169.12
200-Day MA
$160.51
P/E (TTM)
31.74x
Forward P/E
18.31x
PEG Ratio
1.80
Price to Book
31.27x
EPS (TTM)
$5.64
Forward EPS
$9.78
Dividend Yield
1.74%
Beta
1.08
Revenue 2022
$26.16B
Revenue 2023
$24.61B
Revenue 2024
$24.58B
Revenue 2025
$24.95B
Revenue TTM
$25.18B
Gross Profit 2025
$9,957M
Gross Margin 2025
39.9%
Gross Margin (TTM)
39.4%
Operating Income 2025
$4,629M
Operating Margin 2025
18.6%
Operating Margin (TTM)
20.35%
EBITDA 2025
$6,467M
Net Income 2025
$3,250M
Net Margin (TTM)
11.9%
Diluted EPS 2025
$6.00
Diluted EPS 2024
$7.55
Diluted EPS 2023
($12.63)
Diluted EPS 2022
$10.18
Diluted Shares 2024
552M
Diluted Shares Q2-2026
522M
Total Assets 2025
$37,733M
Total Equity 2025
$4,702M
Tangible Book Value 2025
($2,820M)
Total Debt 2025
$12,602M
Total Debt Q2-2026
$12.55B
Net Debt 2025
$7,367M
Net Debt Q2-2026
$9.60B
Cash & Equivalents 2025
$5,235M
Cash Q2-2026
$2.96B
Working Capital 2025
$6,792M
Treasury Stock Q2-2026
$38.18B
Operating Cash Flow 2025
$2,306M
CapEx 2025
$910M
Free Cash Flow 2025
$1,396M
FCF (TTM)
$6.35B
FCF Yield
~6.9%
Dividends Paid 2025
$1,562M
Buybacks 2025
$3,251M
Buybacks 2024
$1,801M
Debt Repaid 2025
$1,815M
Return on Equity
81.9%
Return on Assets
8.74%
Debt/Equity
437.9%
Current Ratio
1.24
Interest Coverage
~6.8x
Net Debt/EBITDA
~1.5x
Revenue 2026-Q1
$6,030M
Revenue 2026-Q2
$6,500M
Operating Income 2026-Q2
$1,320M
Net Income 2026-Q2
$933M
Diluted EPS 2026-Q1
$1.23
Diluted EPS 2026-Q2
$1.78
FCF 2026-Q1
$349M
FCF 2026-Q2
$763M
Forward EPS Growth
+73%
Strengths
Concerns
HOLD — 3M Company is in the late innings of a multi-year corporate restructuring following the Solventum spin-off, with 2024-2025 earnings showing steady normalization and operating margins around 18-20%. The stock trades near its 52-week high with strong momentum but a rich TTM P/E of 31.7x that prices in a successful recovery; the forward P/E of 18.31x reflects analyst consensus for ~73% EPS growth driven by lower litigation costs and margin normalization. The company generates robust FCF of $6.35B TTM supporting aggressive buybacks ($5.05B over 2024-2025) and a safe 4x dividend cover, though rising net debt to $9.60B, ongoing PFAS litigation tail risk, and cyclical end-market exposure warrant prudent position sizing. Recommended action: Existing shareholders HOLD; new entrants wait for a 5-10% pullback to the 50-day MA (~$169) or 200-day MA (~$160) for better risk/reward.
Macro: Decisively disinflationary and rate-cut resistant environment. Polymarket prices 87% probability of zero Fed cuts in 2026; only 8% chance of U.S. recession by year-end. Commodity markets signal caution (silver +18% MoM, gold >$4,640). Soft consumer retail demand confirmed by Walmart's $100B drawdown. Best Buy upside surprise is a lone bright spot. Disinflation intact (6% odds of CPI >5% in 2026).